Lv11
71 积分 2021-04-15 加入
Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial
1小时前
已完结
Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial
1小时前
已完结
Obesityweek 2025 Oral Abstracts
1个月前
已完结
2024 Obesityweek Oral Abstracts
1个月前
已完结
2024 Obesityweek Poster Abstracts
1个月前
已完结
Poster Abstracts
1个月前
已完结
59th EASD Annual Meeting of the European Association for the Study of Diabetes
1个月前
已完结
60th EASD Annual Meeting of the European Association for the Study of Diabetes
1个月前
已完结
61st EASD Annual Meeting of the European Association for the Study of Diabetes
1个月前
已完结
ABSTRACTS FROM THE 43RD ANNUAL MEETING OF THE OBESITY SOCIETY AT OBESITYWEEK® NOVEMBER 4–7, 2025 ISSUE INFORMATION
1个月前
已关闭
皖公网安备34019202002308
